| Biomarker ID | 1761 |
| PMID | 30286478 |
| Year | 2018 |
| Biomarker | CGA (chromogranin A) |
| Biomarker Basis | Concentration Based (ng/mL) |
| Biomolecule | Protein |
| Source | Serum |
| Subjects | Humans |
| Regulation | NA |
| Odds Ratio/Hazard Ratio/Relative Risk | HR: 1.341 (95% CI: 1.011-1.778) |
| Effect on Pathways | NA |
| Experiment | Progression Free Survival Vs No Progression Free Survival |
| Type of Biomarker | Prognostic |
| Cohort | 23 patients with CRPC were included in the study. 4 serum collections were not feasable after study. 19 samples were avaliable, with change from baseline. |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p=0.0416 |
| Method Used | NA |
| Clinical | Yes |
| Remarks | Trial Not registered with NCT but, site: Germanctr.de |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |